WINNIPEG, MB, May 30, 2013 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") today announced the appointment of James
Hickey to the company's board of directors effective June 1, 2013.
Mr. Hickey is an experienced medical device industry executive who
brings more than 25 years of experience in building, managing and
leading successful medical technology companies. He began his career
with American Hospital Supply/Baxter Healthcare in 1977. Subsequently
he has served as the CEO of two publicly traded and two private medical
device companies and is currently President and CEO of Phraxis, a
medical device developer of vascular access products for the dialysis
market. From 1998 until 2011, Mr. Hickey served on the board of Vital
Images, including having served as the Chair of the Board.
"The addition of Jim to our board brings extensive industry knowledge
and leadership experience that will benefit our company, our customers
and our shareholders," said David Graves, Chairman of the Board of
Directors. "Jim's contribution to the strategic thinking in
combination with his broad industry experience will make a meaningful
difference to IMRIS."
Mr. Hickey has served on numerous medical device boards and was honored
by Twin Cities Business Monthly as one of their "Corporate Directors of
the Year" in 2005.
"I am delighted to join the IMRIS' board of directors," said Mr.
Hickey. "IMRIS' VISIUS® Surgical Theatre is the leading technology in the market, and with the
development of the SYMBIS™ Surgical Robotic System, has the potential
to improve outcomes for patients while reducing the cost of care. I
look forward to contributing to the growth of the company."
Mr. Hickey will replace Mr. Robert Courteau who has resigned from the
board of directors effective May 31, 2013.
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. VISIUS Surgical Theatres
serve the neurosurgical, cardiovascular and cerebrovascular markets and
have been selected by leading medical institutions around the world.
SOURCE: IMRIS Inc.
For further information: